Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
作者信息
Lee Eun-Ju, Cines Douglas B, Gernsheimer Terry, Kessler Craig, Michel Marc, Tarantino Michael D, Semple John W, Arnold Donald M, Godeau Bertrand, Lambert Michele P, Bussel James B
机构信息
Division of Hematology, New York Presbyterian Hospital - Weill Cornell, New York, New York.
Division of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
Abstract
摘要
相似文献
1
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.辉瑞和莫德纳新冠疫苗接种后出现的血小板减少症。
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
2
Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature.新型冠状病毒肺炎疫苗接种后严重免疫性血小板减少症：4例报告及文献复习
Blood Cells Mol Dis. 2021 Dec;92:102615. doi: 10.1016/j.bcmd.2021.102615. Epub 2021 Oct 7.
3
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.一名22岁接种新冠疫苗后出现的免疫性血小板减少症。
Am J Hematol. 2021 May 1;96(5):E133-E134. doi: 10.1002/ajh.26106. Epub 2021 Feb 11.
4
Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia.慢性或持续性免疫性血小板减少症患者接种新冠疫苗后的血小板变化趋势
Am J Hematol. 2021 Dec 1;96(12):E472-E474. doi: 10.1002/ajh.26366. Epub 2021 Oct 19.
5
Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.辉瑞-BioNTech BNT162b2 mRNA新冠疫苗接种后出现免疫性血小板减少症
Isr Med Assoc J. 2021 Jun;23(6):341.
6
AZD1222 vaccine-related coagulopathy and thrombocytopenia without thrombosis in a young female.一名年轻女性出现与AZD1222疫苗相关的凝血障碍和血小板减少症，无血栓形成。
Br J Haematol. 2021 Aug;194(3):553-556. doi: 10.1111/bjh.17530. Epub 2021 May 25.
7
Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.免疫性血小板减少症患者接种抗SARS-CoV-2疫苗的安全性
Br J Haematol. 2021 Dec;195(5):703-705. doi: 10.1111/bjh.17813. Epub 2021 Aug 31.
8
Exacerbation of immune thrombocytopenia following COVID-19 vaccination.接种 COVID-19 疫苗后免疫性血小板减少症恶化。
Br J Haematol. 2021 Nov;195(3):365-370. doi: 10.1111/bjh.17645. Epub 2021 Jun 24.
9
The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia.静脉注射免疫球蛋白在疫苗诱导的免疫性血栓性血小板减少症治疗中的应用。
Blood. 2021 Sep 16;138(11):992-996. doi: 10.1182/blood.2021012479.
10
Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.治疗性血浆置换在疫苗诱导的免疫性血栓性血小板减少症中的应用
N Engl J Med. 2021 Aug 26;385(9):857-859. doi: 10.1056/NEJMc2109465. Epub 2021 Jul 7.
引用本文的文献
1
Impact of COVID-19 vaccination on cancer patients: safety, efficacy, and long-term effects.2019冠状病毒病疫苗接种对癌症患者的影响：安全性、有效性及长期影响
Support Care Cancer. 2025 Aug 4;33(8):753. doi: 10.1007/s00520-025-09783-1.
2
Autoimmune Hepatitis and Drug-Induced Liver Injury in Japan.日本的自身免疫性肝炎和药物性肝损伤
J Clin Med. 2025 Jun 25;14(13):4514. doi: 10.3390/jcm14134514.
3
Robotic Splenectomy as a Salvage Therapy Post Failed Splenic Embolization in Chronic Immune Thrombocytopenic Purpura Due to the COVID-19 Vaccine.机器人脾切除术作为新冠疫苗所致慢性免疫性血小板减少性紫癜脾栓塞失败后的挽救性治疗
Cureus. 2025 Mar 31;17(3):e81536. doi: 10.7759/cureus.81536. eCollection 2025 Mar.
4
Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development.超越新冠病毒的起源：新冠疫苗研发五年历程中的重要战略层面
Mol Ther Nucleic Acids. 2025 Mar 28;36(2):102527. doi: 10.1016/j.omtn.2025.102527. eCollection 2025 Jun 10.
5
Advances in Virus Biorecognition and Detection Techniques for the Surveillance and Prevention of Infectious Diseases.用于传染病监测与预防的病毒生物识别及检测技术进展
Biosensors (Basel). 2025 Mar 20;15(3):198. doi: 10.3390/bios15030198.
6
Leukocyte Count in Solid Organ Transplant Recipients After SARS-CoV-2 mRNA Vaccination and Infection.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗接种和感染后实体器官移植受者的白细胞计数
Vaccines (Basel). 2025 Jan 22;13(2):103. doi: 10.3390/vaccines13020103.
7
Immune thrombocytopaenic purpura following the second dose of Pfizer COVID-19 vaccine.第二剂辉瑞新冠疫苗接种后出现免疫性血小板减少性紫癜
BMJ Case Rep. 2022 Sep 2;15(9):e249477. doi: 10.1136/bcr-2022-249477.
8
COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.特立尼达和多巴哥的新冠疫苗有效性与安全性：一项系统评价与荟萃分析
Microorganisms. 2025 Jan 10;13(1):135. doi: 10.3390/microorganisms13010135.
9
Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review.揭示新冠疫苗的心血管风险与益处：一项系统评价
Cardiovasc Toxicol. 2025 Feb;25(2):306-323. doi: 10.1007/s12012-024-09954-2. Epub 2025 Jan 18.
10
Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy.两例与腺病毒载体疫苗ChAdOx1-S（阿斯利康）相关的免疫性血小板减少症（ITP）及血小板生成素受体激动剂（TPO-RA）治疗后的良好反应
Hematol Rep. 2024 Sep 27;16(4):585-592. doi: 10.3390/hematolrep16040057.
本文引用的文献
1
Acute Immune Thrombocytopenia following administration of Shingrix recombinant zoster vaccine.接种重组带状疱疹疫苗（Shingrix）后发生的急性免疫性血小板减少症。
Am J Hematol. 2021 May 1;96(5):E136-E137. doi: 10.1002/ajh.26143. Epub 2021 Mar 11.
2
Familial thrombocytopenia flare-up following the first dose of mRNA-1273 Covid-19 vaccine.第一剂mRNA-1273新冠疫苗接种后家族性血小板减少症发作
Am J Hematol. 2021 May 1;96(5):E134-E135. doi: 10.1002/ajh.26128. Epub 2021 Mar 1.
3
Antibody-induced procoagulant platelets in severe COVID-19 infection.严重 COVID-19 感染中的抗体诱导的促凝血小板。
Blood. 2021 Feb 25;137(8):1061-1071. doi: 10.1182/blood.2020008762.
4
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.一名22岁接种新冠疫苗后出现的免疫性血小板减少症。
Am J Hematol. 2021 May 1;96(5):E133-E134. doi: 10.1002/ajh.26106. Epub 2021 Feb 11.
5
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
7
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.新型冠状病毒肺炎继发免疫性血小板减少症：一项系统评价
SN Compr Clin Med. 2020;2(11):2048-2058. doi: 10.1007/s42399-020-00521-8. Epub 2020 Sep 19.
8
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.新型冠状病毒肺炎相关免疫性血小板减少症的临床特征、管理及结局：一项法国多中心研究系列
Br J Haematol. 2020 Aug;190(4):e224-e229. doi: 10.1111/bjh.17024. Epub 2020 Aug 4.
9
Safety of antisense oligonucleotide and siRNA-based therapeutics.基于反义寡核苷酸和小干扰RNA的治疗药物的安全性。
Drug Discov Today. 2017 May;22(5):823-833. doi: 10.1016/j.drudis.2017.01.013. Epub 2017 Jan 31.
10
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.与疫苗接种相关的免疫性血小板减少性紫癜（ITP）：病例报告综述
Immunol Res. 2014 Dec;60(2-3):226-35. doi: 10.1007/s12026-014-8597-x.
Zotero 插件